Detalles de la búsqueda
1.
Innovative cell therapy in the treatment of serious adverse events related to both chemo-radiotherapy protocol and acute myeloid leukemia syndrome: the infusion of mesenchymal stem cells post-treatment reduces hematopoietic toxicity and promotes hematopoietic reconstitution.
Curr Pharm Biotechnol
; 14(9): 842-8, 2013.
Artículo
en Inglés
| MEDLINE | ID: mdl-24372262
Resultados
1 -
1
de 1
1
Próxima >
>>